Xyence Capital is an asset management firm that invests in people, ideas and technologies that can transform the future of life sciences.
We work together with entrepreneurs and researchers to develop revolutionary companies that improve human health.
We support ambitious start-ups and early-stage SMEs with innovative products globally, primarily in Europe and the United States.
Principia II Fund
It has completed 30 investments and currently has 2 operating companies in its portfolio
Principia III – Health Fund
It has completed a total of 16 investments.
There are currently 9 portfolio companies operating in the Biopharma, Medical Device, Healthcare Services and Digital Health sectors
Chief Executive Officer & Board Member
Chief Financial Officer
Corporate Affairs Manager